Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin

Jiri Trcka1, Cornelia S Seitz, Eva-B Bröcker

  • 1Department of Dermatology, Venerology and Allergology, University of Würzburg, Würzburg, Germany.

Abstract

Insights

Patients with aminopenicillin-induced exanthema can often tolerate specific cephalosporins or phenoxymethyl penicillin. Allergy testing helps identify safe beta-lactam antibiotics, avoiding less effective alternatives and antibiotic resistance.

Area of Science:

  • Infectious Diseases
  • Clinical Immunology
  • Pharmacology

Background:

  • Aminopenicillin-induced exanthema complicates infectious disease management.
  • Cross-reactivity concerns often lead to avoidance of all beta-lactams.
  • Alternative antibiotics may be less effective and contribute to resistance.

Purpose of the Study:

  • To demonstrate that patients with aminopenicillin-induced exanthema can safely receive specific beta-lactams.
  • To evaluate the potential for cross-reactivity between aminopenicillins and other beta-lactams.
  • To provide evidence for personalized antibiotic selection in allergic patients.

Main Methods:

  • Skin testing followed by oral challenges.
  • Identification of tolerated beta-lactams in patients with confirmed hypersensitivity.
  • Focus on non-immunoglobulin E (IgE)-mediated reactions.

Main Results:

  • 97.2% of patients tolerated cephalosporins lacking an aminobenzyl side chain (e.g., cefpodoxime, cefixime).
  • 71.8% of patients tolerated phenoxymethyl penicillin.
  • High tolerance rates suggest limited cross-reactivity in this patient group.

Conclusions:

  • Most patients with non-IgE-mediated hypersensitivity to aminopenicillins tolerate certain cephalosporins and phenoxymethyl penicillin.
  • Skin and drug challenge tests are valuable for assessing individual cross-reactivity.
  • This approach can guide safer antibiotic selection and reduce reliance on alternative agents.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...